PROCEPT BioRobotics Corporation (PRCT) short interest & options flow
NASDAQPROCEPT BioRobotics heads into the post-earnings stretch with analysts slashing price targets and the stock trading at $18.28 — down 13% over the past month and sitting well below where most of the Street was positioned just weeks ago. The analyst reaction has been swift and broad. TD Cowen trimmed its target from $34 to $28 on August 5, while Piper Sandler cut from $35 to $25 and…
PRCT cost to borrow surges to 0.446%, up 111% over one week, as short interest holds at 12.3% of float.
- Market cap
- $1.29B
- Next earnings
- 25 Feb 2027
Key data as of 10 Nov 2026
Latest signals on PRCT
- Cost to Borrow
PRCT cost to borrow surges to 0.446%, up 111% over one week, as short interest holds at 12.3% of float.
PRCT news and analysis
RSSNo long-form analysis yet for PRCT. Pulse alerts and the live data picture are available on ORTEX.
Open PRCT on ORTEX →Want the live picture for PRCT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PRCT — free to start on ORTEX.
Sign up for free →Open PRCT on ORTEX